Target intelligence / Profile preview

DNA topoisomerase 1 - DNA cleavage complex (Top1cc)

Target
Top1cc
Molecular classification
Enzyme, Isomerase, DNA-binding protein
01

Overview

DNA topoisomerase 1 (Top1) is an essential nuclear enzyme that regulates DNA topology by inducing transient single-strand breaks, allowing DNA to rotate and relieve torsional strain during replication and transcription (NIH, 2020). The Top1-DNA cleavage complex (Top1cc) is the catalytic intermediate where the enzyme is covalently attached to the 3-prime phosphate end of the DNA (MDPI, 2020). This complex is the primary molecular target for anticancer agents known as Top1 poisons, such as irinotecan and topotecan, which act as interfacial inhibitors by binding at the enzyme-DNA interface to stabilize the Top1cc (NIH, 1998; AACR, 2020). Stabilization prevents DNA religation, leading to lethal double-strand breaks when replication forks or transcription complexes collide with the trapped enzyme (Wikipedia, 2020). Beyond cancer, Top1 is a target of autoantibodies in systemic sclerosis, indicating its role in autoimmune pathology (NIH, 2020). Clinical response to Top1 inhibitors is often influenced by biomarkers like SLFN11 expression and the activity of repair enzymes such as TDP1 (AACR, 2020). However, these therapies are associated with significant safety concerns, including severe gastrointestinal toxicity and myelosuppression (NIH, 2020).

Other names
Topoisomerase ITOP1Top1-DNA covalent complexTop1 cleavage complexTop1-DNA CC
02

Mechanism of action

Interfacial inhibition; stabilization of the covalent Top1-DNA cleavage complex (Top1cc), preventing DNA religation and leading to replication-mediated double-strand breaks.

03

Biological functions

DNA replicationTranscriptionDNA repairChromatin remodelingRelieving DNA torsional strainSuppressing R-loop formation
04

Disease associations

CancerSystemic sclerosis
05

Safety considerations

Myelosuppression (neutropenia, anemia)Gastrointestinal toxicity (severe diarrhea)GenotoxicityNeurotoxicity
06

Interacting drugs

Camptothecin

6 more in the full profile.

07

Biomarkers

SLFN11 expressionTOP1 expressionTDP1 activityPARP1 expressionBRCA1/2 status (HRD)

Beyond the preview

Go deeper on DNA topoisomerase 1 - DNA cleavage complex (Top1cc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA topoisomerase 1 - DNA cleavage complex (Top1cc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call